A catastrophic failure in European fertility industry oversight has resulted in nearly 200 children being born with a deadly cancer-causing gene from a single sperm donor, exposing dangerous regulatory gaps that put profits over family protection.
Story Snapshot
- Single sperm donor with cancer gene fathered 197 children across 14 European countries over 17 years
- Children face 90% lifetime cancer risk; some have already died from the inherited mutation
- European Sperm Bank’s screening failed to detect TP53 gene mutation causing Li Fraumeni syndrome
- International regulatory failures allowed widespread distribution despite national limits being exceeded
Screening System Catastrophically Failed Families
The European Sperm Bank approved a donor in 2005 whose genetic material carried a devastating TP53 gene mutation, despite screening protocols supposedly designed to protect recipients. This mutation causes Li Fraumeni syndrome, giving affected individuals a 90% chance of developing cancer during their lifetimes.
Up to 20% of the donor’s sperm contained this deadly genetic flaw, meaning any children conceived would carry the mutation in every cell of their bodies. The screening failure represents a fundamental breakdown in protecting families seeking reproductive assistance.
Sperm from donor with cancer-causing gene was used to conceive almost 200 children https://t.co/o8LZs6ua5H
— BBC News (UK) (@BBCNews) December 10, 2025
Children Already Paying the Ultimate Price
Tragically, some children have already died from cancers linked to this inherited genetic defect, with others developing multiple cancers at extremely young ages.
Cancer geneticist Edwige Kasper from France’s Rouen University Hospital confirmed that “some children have developed already two different cancers and some of them have already died at a very early age.”
Of 67 initially identified children from this donor, 23 were found to carry the genetic mutation, with 10 already diagnosed with cancer. This represents a devastating outcome for families who trusted the fertility industry to provide healthy genetic material.
Regulatory Chaos Enabled International Disaster
The European Sperm Bank distributed this donor’s genetic material to 67 fertility clinics across 14 countries, exposing critical gaps in international oversight. While individual nations maintain domestic limits on donor usage, no international framework exists to prevent worldwide overuse of single donors.
Belgium’s investigation revealed flagrant violations of national laws, with 53 children born to 38 women from the defective donor despite regulations limiting single donors to six families maximum. This regulatory patchwork allowed dangerous genetic material to spread unchecked across continental Europe.
Discovery Through Medical Detective Work
The crisis only came to light when doctors treating children with unusual cancer patterns raised concerns at the European Society of Human Genetics conference. Medical professionals noticed clustering of rare cancers among children conceived through sperm donation, prompting investigation.
Freedom of Information requests by journalists across multiple countries ultimately revealed the scope of the disaster, uncovering at least 197 affected children.
Cancer geneticist Clare Turnbull described the diagnosis as “dreadful” and “clearly devastating,” noting the “lifelong burden of living with that risk” these families now face.
American Families Protected by Stricter Standards
The European Sperm Bank confirmed it does not ship to the United States due to stricter American regulations, though it maintains relationships with facilities in Canada and Mexico.
This regulatory difference potentially protected American families from this particular disaster, highlighting how proper oversight can prevent such catastrophic outcomes.
The contrast underscores the importance of robust screening protocols and international coordination in protecting families seeking reproductive assistance. However, the bank’s connections to neighboring countries raises questions about potential indirect exposure risks.
